Ensitrelvir in patients with SARS-CoV-2: A retrospective chart review-Reference-Cited by-同舟云学术

Ensitrelvir in patients with SARS-CoV-2: A retrospective chart review

Published:2024-09 Issue:9 Volume:30 Page:946-950
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Yamato Masaya,Kinoshita Masahiro,Miyazawa Shogo,Seki Masayuki,Mizuno Tomoki,Sonoyama Takuhiro^ORCID

Funder

Shionogi

Publisher

Elsevier BV

Reference15 articles.

1. SARS-CoV-2 Omicron variant neutralization in serum from vaccinated and convalescent persons;Rössler;N Engl J Med,2022

2. A review on the impact of the SARS-CoV-2 Omicron subvariant on elderly patients with diverse co-morbidities;Khadela;Biologics,2023

3. Is Omicron really mild? – Comparative analysis of comorbidities and disease outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants;Manchanda;Indian J Med Microbiol,2023

4. Outcomes of elderly patients hospitalized with the SARS-CoV-2 Omicron B.1.1.529 variant: a systematic review;Fericean;Int J Environ Res Publ Health,2023

5. Immunocompromised patients with protracted COVID-19: a review of "long persisters";Dioverti;Curr Transplant Rep,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approach to prolonged viral pneumonia in immunocompromised patients with COVID-19;CMI Communications;2024-12

2. SARS-CoV-2 replication and drug discovery;Molecular and Cellular Probes;2024-10

3. Real-World Effectiveness of Ensitrelvir in Reducing Severe Outcomes in Outpatients at High Risk for COVID-19;Infectious Diseases and Therapy;2024-06-28

4. Ensitrelvir Fumaric Acid: First Approval;Drugs;2024-05-25

5. RNA Polymerase Inhibitor Enisamium for Treatment of Moderate COVID-19 Patients: A Randomized, Placebo-Controlled, Multicenter, Double-Blind Phase 3 Clinical Trial;Advances in Respiratory Medicine;2024-05-06